Establishing an Autopsy-Based Cerebrospinal Fluid Biomarker Signature in Alzheimer Disease Patients

CLINICAL CHEMISTRY(2022)

引用 0|浏览4
暂无评分
摘要
Journal Article Establishing an Autopsy-Based Cerebrospinal Fluid Biomarker Signature in Alzheimer Disease Patients Get access Leslie M Shaw, Leslie M Shaw University of Pennsylvania Perelman School of Medicine, Department of Pathology and Laboratory Medicine, Philadelphia, PA, USA Address correspondence to this author at: Perelman School of Medicine, Department of Pathology and Laboratory Medicine, 3400 Spruce St., Philadelphia, PA 19104, USA. Fax 215-662-7529; e-mail shawlmj@pennmedicine.upenn.edu. Search for other works by this author on: Oxford Academic Google Scholar Hugo Vanderstichele, Hugo Vanderstichele Biomarkable, Gent, Belgium Search for other works by this author on: Oxford Academic Google Scholar Malgorzata Knapik-Czajka, Malgorzata Knapik-Czajka Jagiellonian University in Kraków Medical College, Krakow, Małopolskie, Poland https://orcid.org/0000-0002-6545-5159 Search for other works by this author on: Oxford Academic Google Scholar Kaj Blennow, Kaj Blennow Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg Sahlgrenska Academy, Goteborg, Sweden Search for other works by this author on: Oxford Academic Google Scholar John Q Trojanowski John Q Trojanowski University of Pennsylvania Perelman School of Medicine, Department of Pathology and Laboratory Medicine, Philadelphia, PA, USA Search for other works by this author on: Oxford Academic Google Scholar Clinical Chemistry, Volume 68, Issue 10, October 2022, Pages 1336–1337, https://doi.org/10.1093/clinchem/hvac137 Published: 30 August 2022 Article history Received: 13 July 2022 Accepted: 18 July 2022 Published: 30 August 2022
更多
查看译文
关键词
cerebrospinal fluid biomarker signature,alzheimer disease,autopsy-based
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要